1 Comment

There is insufficient evidence for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of fluvoxamine for the treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/fluvoxamine/

Expand full comment